Arrowhead Pharmaceuticals Inc (ARWR) stock is higher by 60.11% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ARWR stock a score of 77 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 84. ARWR's rank also includes a short-term technical score of 83. The fundamental score for ARWR is 63. In addition to the average rating from Wall Street analysts, ARWR stock has a mean target price of 66.5. This means analysts expect the stock to gain 47.91% over the next 12 months.
What's Happening with ARWR Stock Today
Arrowhead Pharmaceuticals Inc (ARWR) stock is higher by 2.65% while the S&P 500 is down -1.22% as of 2:10 PM on Wednesday, Sep 23. ARWR is higher by $1.16 from the previous closing price of $43.80 on volume of 1,069,576 shares. Over the past year the S&P 500 has risen 10.40% while ARWR is higher by 60.11%. ARWR lost -$0.24 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Arrowhead Pharmaceuticals Inc (ARWR) Stock.